Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma.

Ooki, Akira; Osumi, Hiroki; Chin, Keisho; Watanabe, Masayuki; Yamaguchi, Kensei

Ooki, Akira; Osumi, Hiroki; Chin, Keisho; Watanabe, Masayuki; Yamaguchi, Kensei.

Affiliation

Ooki A; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
Osumi H; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Chin K; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Watanabe M; Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Yamaguchi K; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Ther Adv Med Oncol ; 15: 17588359221138377, 2023.

Article de En | MEDLINE | ID: mdl-36872946

Mots clés

chemotherapy; esophageal cancer; esophageal squamous cell carcinoma; immunotherapy; molecular-targeted therapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Ther Adv Med Oncol Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google